|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
5
|
Resverlogix Corp.
|
Dec 05, 2019 07:24PM
|
|
SGLT2 synergy
|
11
|
Resverlogix Corp.
|
Nov 18, 2019 12:11PM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:27PM
|
|
Re: AE/LFT concerns
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 05:39PM
|
|
Re: Do we know what RRR % we got for 5 point MACE
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 04:30PM
|
|
Re: My general impressions
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 04:15PM
|
|
Thoughts on value
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 04:09PM
|
|
Re: Sub-study Forest Plot
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 03:00PM
|
|
Re: AGM comment - Monday more important than today?
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 02:30PM
|
|
Re: Tweet
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 02:15PM
|
|
AGM comment - Monday more important than today?
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 01:59PM
|
|
Re: A few thoughts
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 01:42PM
|
|
A few thoughts
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 12:52PM
|
|
Re: Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
7
|
Resverlogix Corp.
|
Nov 12, 2019 11:06AM
|
|
Re: AMRN is up big time this am
|
6
|
Resverlogix Corp.
|
Nov 12, 2019 08:38AM
|
|
Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
5
|
Resverlogix Corp.
|
Nov 12, 2019 07:35AM
|
|
Looking at the language from the press release
|
10
|
Resverlogix Corp.
|
Oct 05, 2019 12:43PM
|
|
Re: Interesting comment from DM
|
9
|
Resverlogix Corp.
|
Sep 30, 2019 12:05PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 10:38AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
6
|
Resverlogix Corp.
|
Sep 30, 2019 10:20AM
|
